Torrent Pharmaceuticals Limited

NSE:TORNTPHARM.NS

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

💊 Pharmaceuticals

Location

India

Market Cap

USD 13.88 B

Share Price

USD 40.74

Avg Daily Volume

481,193

Change (1 day)

-0.96%

Change (1 year)

2.64%

Change (YTD)

3.79%

Torrent Pharmaceuticals Limited EBITDA Margin for the year ending March 31, 2025: 32.88%

Torrent Pharmaceuticals Limited EBITDA Margin is 32.88% for the year ending March 31, 2025, a -0.40% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Torrent Pharmaceuticals Limited EBITDA Margin for the year ending March 31, 2024 was 33.01%, a 9.21% change year over year.
Torrent Pharmaceuticals Limited EBITDA Margin for the year ending March 31, 2023 was 30.23%, a 20.01% change year over year.
Torrent Pharmaceuticals Limited EBITDA Margin for the year ending March 31, 2022 was 25.19%, a -21.69% change year over year.
Torrent Pharmaceuticals Limited EBITDA Margin for the year ending March 31, 2021 was 32.16%, a 9.33% change year over year.